Vaccines

Novel Cancer Immunotherapy Approaches For The Treatment And Prevention Of Cancer
Background: The National Cancer Institute's Laboratory of Tumor Immunology and Biology is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize cancer immunotherapy using costimulation.  See (more...)
(Full Text)

Method For Efficient Delivery Of Proteins Into Cells
Background: The National Cancer Institute's Protein Expression Laboratory is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize methods for delivery of proteins using virus-like particles. Proteins (more...)
(Full Text)

Novel Therapeutics for the Treatment and Prevention of Avian Influenza
Background: The National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize cyanovirin-N for use against H5N1 influenza. The technology is also available (more...)
(Full Text)

Uses of Cyanovirin-N for Anti-Hiv and Anti-Influenza Therapeutics and Prophylactics
Keywords: Therapeutics, Vaccines, HIV, Influenza, Cyanovirin-N (CV-N) Background: The National Cancer Institute's Molecular Targets Laboratory is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize cyanovirin-N HIV (more...)
(Full Text)

Method To Inactivate Viruses For Vaccine Development
Background: The National Cancer Institute's Nanobiology Program is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the use of hydrophobic crosslinkers for vaccine development using (more...)
(Full Text)